HSDT - ヘリウス・メディカル・テクノロジ―ズ (Helius Medical Technologies Inc.) ヘリウス・メディカル・テクノロジ―ズ

 HSDTのチャート


 HSDTの企業情報

symbol HSDT
会社名 Helius Medical Technologies Inc (ヘリウス・メディカル・テクノロジ―ズ)
分野(sector) Health Care   ヘルスケア
産業(industry) Biotechnology: Electromedical_Electrotherapeutic Apparatus  
業種    医療関連(Health Care)
概要 事業概要 --   ヘリウス・メディカル・テクノロジ―ズは米国の医療機器メ―カ―。主に病気や外傷による神経疾患治療に注力した医療用機器の研究・開発に従事する。同社の携帯型装置「PoNS」は、舌から電気パルスを送り、三叉神経や顔面神経に刺激を与えることにより脳機能を高める治療を行う。本社所在地はペンシルベニア州ニュ―タウン。   Helius Medical Technologies is a neurotech company focused on neurological wellness. The Company's purpose is to develop, license and acquire unique and non-invasive platform technologies that amplify the brain's ability to heal itself. The Company's first commercial product is the Portable Neuromodulation Stimulator (PoNSTM).
本社所在地 642 Newtown Yardley Road Suite 100 Newton PA 18940 USA
代表者氏名
代表者役職名
電話番号
設立年月日 41699
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 50人
url www.heliusmedical.com
nasdaq_url https://www.nasdaq.com/symbol/hsdt
adr_tso
EBITDA EBITDA ー
終値(lastsale) 8.3
時価総額(marketcap) 194033175.3
時価総額 時価総額 ―
売上高 売上高 --
企業価値(EV) 企業価値(EV) ー
当期純利益 当期純利益 --
決算概要 決算概要 --

 HSDTのテクニカル分析


 HSDTのニュース

   Thinking about buying stock in Applied UV, Nio, Wejo Group, Helius Medical Technologies, or Selecta Biosciences?  2022/06/09 13:31:00 Benzinga
NEW YORK , June 9, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AUVI, NIO, WEJO, HSDT, and SELB. … Full story available on Benzinga.com
   Helius Medical Technologies, Inc. Presents Poster at the 2022 Consortium of Multiple Sclerosis Centers (“CMSC”) Annual Meeting  2022/06/06 11:05:00 GlobeNewswire
-- Study finds significant improvement in gait deficit in multiple sclerosis patients using translingual neurostimulation (“PoNS Therapy ® ”) combined with a therapeutic exercise program -- -- Poster was one of ten rehabilitation research presentations nominated for the Labe C. Scheinberg Award recognizing the platform or poster, in each therapeutic category, that has the greatest impact in advancing the care of people with MS --
   Helius Medical Technologies Inc. (NASDAQ: HSDT) Shares Have Been Down About -57.80% Year-To-Date Since The Beginning Of 2022  2022/06/04 17:00:00 Marketing Sentinel
During the last session, Helius Medical Technologies Inc. (NASDAQ:HSDT)’s traded shares were 0.6 million, with the beta value of the company hitting 0.92. At the end of the trading day, the stock’s price was $2.19, reflecting an intraday gain of 9.50% or $0.19. The 52-week high for the HSDT share is $17.26, that puts it … Helius Medical Technologies Inc. (NASDAQ: HSDT) Shares Have Been Down About -57.80% Year-To-Date Since The Beginning Of 2022 Read More »
   Thinking about buying stock in Energy Focus, Helius Medical Technologies, Spark Networks, Sundial Growers, or National Energy Services?  2022/06/02 13:31:00 Benzinga
NEW YORK , June 2, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for EFOI, HSDT, LOV, SNDL, and NESR. … Full story available on Benzinga.com
   FUV, ATNF and LOV among mid-day movers  2022/06/01 17:13:38 Seeking Alpha
Gainers: Tonix Pharmaceuticals Holding TNXP +60%.Helius Medical Technologies HSDT +40%.View VIEW +42%.Spark Networks (LOV) +32%.Regencell Bioscience Holdings (RGC) +21%.180 Life…
   FUV, ATNF and LOV among mid-day movers  2022/06/01 17:13:38 Seeking Alpha
Gainers: Tonix Pharmaceuticals Holding TNXP +60%.Helius Medical Technologies HSDT +40%.View VIEW +42%.Spark Networks (LOV) +32%.Regencell Bioscience Holdings (RGC) +21%.180 Life…
   44 Stocks Moving In Wednesday''s Mid-Day Session  2022/06/01 16:14:08 Benzinga
Gainers Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP ) shares jumped 63.9% to $3.9990 after the company announced the USPTO issued a patent to the company titled "Synthetic Chimeric Poxviruses." After the market closed on Tuesday, Tonix also announced a $12.5 million share repurchase program. Helius Medical Technologies, Inc. (NASDAQ: HSDT ) gained 58% to $2.32. Helius Medical Technologies announced the launch of patient therapy access program for Portable Neuromodulation Stimulator. vTv Therapeutics Inc. (NASDAQ: VTVT ) rose 39% to $0.7701 after the company announced entry into agreements that include a $25 million investment by G42 Investments. View, Inc. (NASDAQ: VIEW ) jumped 28% to $1.6250 as the company reported a rise in FY21 sales. Spark Networks SE (NASDAQ: LOV ) gained 27% to $2.68 after the company announced initiation of exploration of strategic alternatives. CASI Pharmaceuticals, Inc. (NASDAQ: CASI ) jumped 26.3% to $0.4350. Casi Pharmaceuticals recently announced a 1-for-10 reverse stock split effective June 1.
   Helius stock soars 38% on launch of patient program for neuromodulation stimulator therapy  2022/06/01 15:36:44 Seeking Alpha
Helius Medical Technologies (HSDT) stock rose ~38% on June 1 after the company said it launched its Patient Therapy Access Program ((PTAP)).The company said PTAP will…
   Thinking about buying stock in Helius Medical Technologies, Nio, Snap, Digital Turbine, or Aurora Cannabis?  2022/06/01 15:00:00 Benzinga
NEW YORK , June 1, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for HSDT, NIO, SNAP, APPS, and ACB. … Full story available on Benzinga.com
   Helius Medical, Tonix top healthcare gainers; while Enochian, Icosavax lead losers'' pack  2022/06/01 14:04:48 Seeking Alpha
Helius Medical Technologies (HSDT) +57%. Tonix Pharmaceuticals TNXP +49%. Enochian Biosciences ENOB -37%. Icosavax (ICVX) -17%.
   Helius Medical Technologies, Inc. to Present at Two Upcoming Investor Conferences in July  2021/07/12 20:05:00 Intrado Digital Media
NEWTOWN, Pa., July 12, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (Helius or the Company), a neurotech company focused on neurological wellness, today announced that management will participate in the following upcoming investor conferences in July:
   Helius Medical Technologies, Inc. Appoints Antonella Favit-Van Pelt, M.D., Ph.D. as Chief Medical Officer  2021/07/08 11:30:00 Intrado Digital Media
NEWTOWN, Pa., July 08, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (Helius or the Company), a neurotech company focused on neurological wellness, today announced the appointment of Antonella Favit-Van Pelt, M.D., Ph.D. to the position of Chief Medical Officer.
   Helius Medical Technologies, Inc. to Participate in the Annual World Congress of the Society for Brain Mapping and Therapeutics  2021/07/07 21:30:00 Intrado Digital Media
Company Selected to Receive the Pioneer in Technology Award Company Selected to Receive the Pioneer in Technology Award
   Helius Medical Technologies announces new appointments to executive leadership team  2021/06/15 12:57:47 Seeking Alpha
   Helius Medical makes CEO, CFO appointments  2021/06/15 12:38:42 Seeking Alpha

 関連キーワード  (― 米国株 ヘリウス・メディカル・テクノロジ―ズ HSDT Helius Medical Technologies Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)